Ignite Creation Date:
2024-05-06 @ 8:03 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06237244
Status:
COMPLETED
Last Update Posted:
2024-02-05
First Post:
2024-01-23
Brief Title:
Insulin Resistance Indices and Coronary Artery Disease
Sponsor:
Shiraz University of Medical Sciences
Organization:
Shiraz University of Medical Sciences
Study Overview
Official Title:
Predicting the Presence and Severity of Coronary Artery Disease Using Surrogate Markers of Insulin Resistance A Cross-Sectional Study
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this retrospective study from professor Kojuri clinic registry total number of 1017 patients with first angiography were included and all data were recorded from registry Insulin resistance was calculated using laboratory data
Detailed Description:
This was an analytical cross-sectional retrospective study involving patients with suspected CAD who underwent coronary angiography between December 2018 and May 2023 The information was obtained from patients referred to the outpatient cardiovascular clinic Professor Kojuri Cardiology Clinic Shiraz Iran wwwkojuricliniccom Data was extracted from Professor Kojuri Cardiology Clinic database including patients information about the clinical history presence or absence of specific diseases angiographyangioplasty results medications and laboratory values
A total of 14708 patients who had undergone coronary angiography at least once were examined After applying exclusion criteria 1017 eligible cases were selected for data analysis
The following data was recorded for the included patients demographic data past medical history such as DM hypertension etc systolic and diastolic blood pressure weight and height fasting plasma glucose FPG hemoglobin A1c HbA1c total cholesterol TC triglyceride TG low-density lipoprotein cholesterol LDL-C high-density lipoprotein cholesterol HDL-C and serum creatinine Cr Body mass index BMI was calculated as weight Kg divided by the square of height m2 Obesity was defined as BMI 30 Kgm2
Laboratory values were selected from the time before angiography and if not available from the time shortly after the angiography This helped us find those values which could best represent the metabolic state of patients at the time of angiography while reducing the confounding effect of statin use
A total of 14708 patients who had undergone coronary angiography at least once were examined After applying exclusion criteria 1017 eligible cases were selected for data analysis
The following data was recorded for the included patients demographic data past medical history such as DM hypertension etc systolic and diastolic blood pressure weight and height fasting plasma glucose FPG hemoglobin A1c HbA1c total cholesterol TC triglyceride TG low-density lipoprotein cholesterol LDL-C high-density lipoprotein cholesterol HDL-C and serum creatinine Cr Body mass index BMI was calculated as weight Kg divided by the square of height m2 Obesity was defined as BMI 30 Kgm2
Laboratory values were selected from the time before angiography and if not available from the time shortly after the angiography This helped us find those values which could best represent the metabolic state of patients at the time of angiography while reducing the confounding effect of statin use
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None